Literature DB >> 2441858

Characterization of four new cell lines derived from human squamous carcinomas of the uterine cervix.

L R Kelland, L Burgess, G G Steel.   

Abstract

Four continuous cell lines were established from 15 biopsies of human squamous carcinomas of the uterine cervix, two from women less than 35 years old. All four lines grew as adherent monolayers and had epitheloid morphology. All required initial 3T3 feeder layer support and hydrocortisone and insulin for growth and have now been grown in vitro for at least 12 months. The individual lines possessed unique isozyme patterns and were distinct from the HeLa cell line. All were tumorigenic in nude mice. In vitro colony forming efficiencies ranged from 2 to 30% in a monolayer anchorage dependent assay but were only from 0.0025 to 0.6% when assayed in soft agar. The lines were all aneuploid with mean chromosome numbers ranging from 71 to 75. Analysis of intermediate filament expression showed that all lines were positive for cytokeratin expression and two were positive for vimentin expression. These low-passage cell lines represent a panel of new in vitro models of carcinoma of the cervix. They should be useful for the investigation of chemosensitivity, of the involvement of human Papillomavirus in this disease, and as models of squamous cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2441858

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Role of confluent monolayer surfaces on the growth of a newly established human esophageal carcinoma cell line.

Authors:  H Matsuoka; M Mori; H Ueo; K Sugimachi
Journal:  In Vitro Cell Dev Biol       Date:  1990-08

2.  Spatio-temporal dynamics of calcium electrotransfer during cell membrane permeabilization.

Authors:  Alexis Guionet; S Moosavi Nejad; Justin Teissié; Takashi Sakugawa; Sunao Katsuki; Hidenori Akiyama; Hamid Hosseini
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

3.  The intrinsic radiosensitivity and sublethal damage repair capacity of five cervical carcinoma cell lines tested with the 96-well-plate assay.

Authors:  V Rantanen; S Grénman; J Kulmala; R Grénman
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

4.  Analysis of the growth properties and physical state of the human papillomavirus type 16 genome in cell lines derived from primary cervical tumors.

Authors:  L Braun; R Mikumo; H F Mark; S Lauchlan
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

5.  Chemotherapy-radiation interactions in human cervix carcinoma xenografts.

Authors:  K S Tonkin; L R Kelland; G G Steel
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

6.  In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.

Authors:  K J Mellish; L R Kelland; K R Harrap
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

7.  Radiosensitivity and characterisation of a newly established cell line from an epithelioid sarcoma.

Authors:  L R Kelland; L Bingle
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

8.  Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes.

Authors:  C A Hills; L R Kelland; G Abel; J Siracky; A P Wilson; K R Harrap
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

9.  High intrinsic radiosensitivity of a newly established and characterised human embryonal rhabdomyosarcoma cell line.

Authors:  L R Kelland; L Bingle; S Edwards; G G Steel
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

10.  In vitro effects of substance P analogue [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P on human tumour and normal cell growth.

Authors:  M J Everard; V M Macaulay; J L Miller; I E Smith
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.